Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 tesla for local staging of prostate cancer

Bum Soo Kim, Tae Hwan Kim, Tae Gyun Kwon, Eun Sang Yoo

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Abstract

Purpose: Several studies have demonstrated the superiority of endorectal coil magnetic resonance imaging (MRI) over pelvic phased-array coil MRI at 1.5 Tesla for local staging of prostate cancer. However, few have studied which evaluation is more accurate at 3 Tesla MRI. In this study, we compared the accuracy of local staging of prostate cancer using pelvic phased-array coil or endorectal coil MRI at 3 Tesla. Materials and Methods: Between January 2005 and May 2010, 151 patients underwent radical prostatectomy. All patients were evaluated with either pelvic phased-array coil or endorectal coil prostate MRI prior to surgery (63 endorectal coils and 88 pelvic phased-array coils). Tumor stage based on MRI was compared with pathologic stage. We calculated the specificity, sensitivity and accuracy of each group in the evaluation of extracapsular extension and seminal vesicle invasion. Results: Both endorectal coil and pelvic phased-array coil MRI achieved high specificity, low sensitivity and moderate accuracy for the detection of extracapsular extension and seminal vesicle invasion. There were statistically no differences in specificity, sensitivity and accuracy between the two groups. Conclusion: Overall staging accuracy, sensitivity and specificity were not significantly different between endorectal coil and pelvic phased-array coil MRI.

Original languageEnglish
Pages (from-to)550-556
Number of pages7
JournalYonsei Medical Journal
Volume53
Issue number3
DOIs
StatePublished - May 2012

Keywords

  • Comparative study
  • Magnetic resonance imaging
  • Neoplasm staging
  • Prostatic neoplasms

Fingerprint

Dive into the research topics of 'Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 tesla for local staging of prostate cancer'. Together they form a unique fingerprint.

Cite this